# Evaluation

## Agentic Clinical Document Investigation Platform

This document describes the evaluation methodology, acceptance criteria, robustness testing, and release evidence for the current Agentic Clinical Document Investigation Platform release.

The goal of the evaluation program is not simply to measure whether the workflow executes.

It is to determine whether the system:

- produces structurally valid investigation outputs;
- preserves evidence and provenance relationships;
- generates coherent investigation findings;
- handles timeline and medication inconsistencies correctly within the tested dataset;
- routes review-required findings appropriately;
- detects controlled failure conditions;
- recovers correctly after induced failures;
- produces consistent final reports;
- remains reproducible across the frozen release population.

---

# 1. Evaluation Philosophy

The system is evaluated as an investigation pipeline rather than as a generic text-generation model.

The core information hierarchy is:

```text
Clinical Documents
        |
        v
Evidence
        |
        v
Clinical Claims
        |
        v
Investigation Findings
        |
        v
Final Investigation Report
```

The simplified reasoning relationship is:

```text
Evidence -> Claim -> Finding -> Final Report
```

Evaluation therefore focuses on the integrity of this chain.

A final report is not considered trustworthy merely because it is syntactically valid or clinically plausible.

The evaluation process also examines whether:

- findings are traceable to upstream evidence;
- case identity remains consistent;
- finding counts are consistent across workflow and report artifacts;
- review status is consistent;
- malformed or incomplete inputs fail deterministically;
- recovery restores valid behavior.

---

# 2. What Is a Finding?

A finding is a structured investigation conclusion generated after the system analyzes:

- evidence items;
- clinical claims;
- timeline events;
- medication information;
- relationships across documents;
- contradictions;
- missing follow-up;
- potentially unsupported claims.

A finding is not simply a raw clinical fact extracted from a source document.

The current finding categories are:

```text
timeline_conflict
temporal_uncertainty
medication_discrepancy
contradiction
missing_follow_up
unsupported_claim
other
```

This distinction is important when interpreting the reported total of 317 findings.

The number represents structured investigation conclusions in the frozen release population, not 317 source-document facts.

---

# 3. Evaluation Scope

The current release evaluation covers:

```text
20 investigation cases
317 investigation findings
1 review-required finding
316 contextual findings
1 case requiring human review
```

The evaluation population is deterministic and frozen for release acceptance.

The current release is based on synthetic clinical data and generated clinical documents.

Generated document types include:

```text
admission_note.md
progress_note.md
lab_report.md
medication_reconciliation.md
discharge_summary.md
follow_up_note.md
```

The results in this document apply to that release population and the defined evaluation conditions.

---

# 4. Evaluation Stages

The release evaluation is divided into two major phases:

```text
Step 8 - Evaluation & Refinement
Step 9 - End-to-End Acceptance Testing
```

Step 8 was used to establish and refine the quality baseline.

Step 9 was used to determine whether the integrated system was acceptable as a frozen release.

---

# 5. Step 8 - Evaluation & Refinement

Step 8 focused on identifying quality issues in investigation outputs and resolving known defects before release acceptance.

The final Step 8 gate reported:

```text
Status:                    PASS
Cases:                     20
Findings:                  317
Review-required findings:  1
Contextual findings:       316
Historical defects fixed:  4
Frozen artifacts:          9
```

Step 8 is complete and frozen.

---

# 6. Step 8 Evaluation Goals

Step 8 evaluated areas including:

- finding quality;
- provenance consistency;
- evidence references;
- timeline consistency;
- medication reconciliation behavior;
- review-routing behavior;
- final-report integrity;
- known historical defects.

The purpose of Step 8 was to ensure that obvious quality defects were addressed before beginning release-level acceptance testing.

---

# 7. Historical Defect Resolution

Four historical defects were resolved before the Step 8 freeze.

The final Step 8 release baseline therefore represents the corrected system rather than the earlier intermediate implementation state.

These resolved defects are part of the reason Step 8 was frozen before Step 9 began.

Step 9 acceptance testing consumes the frozen Step 8 baseline rather than redefining it.

---

# 8. Step 9 - End-to-End Acceptance Testing

Step 9 evaluates the system as an integrated release candidate.

It contains four gates:

```text
9A - End-to-End Regression
9B - Robustness Testing
9C - Final Report / Human Review Acceptance
9D - Release-Readiness Freeze
```

All four gates passed.

---

# 9. Step 9A - End-to-End Regression

Step 9A validates the production workflow across the full frozen release population.

The evaluation runs the integrated investigation system and audits persisted outputs.

The objective is to verify that the accepted Step 8 behavior remains intact when the complete system is executed end to end.

Final Step 9A result:

```text
PASS
```

Population accepted:

```text
20 / 20 cases
317 / 317 findings
```

---

# 10. What Step 9A Validates

The end-to-end regression gate checks areas including:

- case execution completion;
- persisted investigation artifacts;
- final report generation;
- case identity consistency;
- finding population consistency;
- validation status;
- human-review status;
- expected release population totals.

The evaluation uses persisted outputs rather than relying only on transient in-memory workflow state.

This is important because a production workflow can appear successful in memory while failing to persist correct artifacts.

---

# 11. Persisted Output Validation

The release audit validates consistency between the workflow result and the final report.

Important consistency relationships include:

```text
workflow case_id
    ==
final report case_id
```

```text
workflow finding count
    ==
final report finding_count
```

```text
workflow review_status
    ==
final report review_status
```

The application runner introduced during Step 10A also enforces these basic consistency relationships during release-facing execution.

---

# 12. Step 9B - Robustness Testing

Step 9B evaluates whether the system behaves safely and predictably when important artifacts or data relationships are deliberately damaged.

This is not intended as exhaustive adversarial testing.

It is controlled mutation testing of known system dependencies and failure boundaries.

Final Step 9B result:

```text
PASS
```

Results:

```text
Robustness mutations:       49 / 49
Repeated failure runs:      10 / 10
Successful recoveries:      10 / 10
```

---

# 13. Meaning of the 49 Robustness Mutations

The 49 mutations are controlled perturbations applied to the investigation environment or persisted artifacts.

They are designed to test whether the system correctly handles defined failure scenarios.

The mutation population includes areas such as:

- missing required artifacts;
- partial artifacts;
- malformed JSON;
- schema-invalid data;
- provenance breakage;
- timeline perturbation;
- medication perturbation;
- artifact inconsistency;
- required-reference failures.

A result of:

```text
49 / 49
```

means all 49 defined mutation scenarios behaved according to their expected acceptance criteria.

It does not mean the system has been tested against every possible real-world failure condition.

---

# 14. Deterministic Failure Testing

Step 9B also includes repeated failure runs.

Final result:

```text
10 / 10 repeated failure runs
```

The purpose is to determine whether a known invalid state fails consistently rather than producing unstable or nondeterministic behavior.

For a controlled invalid case:

```text
same invalid condition
        |
        v
repeated execution
        |
        v
consistent failure behavior
```

This is important for operational reliability because silent or inconsistent failure behavior is more dangerous than a deterministic rejection.

---

# 15. Recovery Testing

After inducing failures, the affected artifacts or conditions are restored.

The workflow is then executed again.

Final result:

```text
10 / 10 successful recoveries
```

This verifies that:

```text
valid baseline
    |
    v
induced failure
    |
    v
expected failure
    |
    v
restore valid state
    |
    v
successful execution
```

The recovery test helps distinguish persistent system corruption from correctly isolated input or artifact failures.

---

# 16. Robustness Acceptance Model

A robustness scenario is not considered successful merely because the system raises an exception.

The expected outcome depends on the mutation.

A scenario may require:

- deterministic rejection;
- explicit validation failure;
- controlled workflow failure;
- protection against invalid report generation;
- correct recovery after artifact restoration.

The acceptance criteria are therefore scenario-specific.

---

# 17. Step 9C - Final Report and Human Review Acceptance

Step 9C evaluates whether the final report and human-review behavior are consistent with the investigation state.

Final status:

```text
PASS
```

The final release population contains:

```text
317 findings
1 review-required finding
316 contextual findings
1 case requiring human review
```

---

# 18. Review-Status Contract

The production workflow uses two principal release states.

When human review is not required:

```text
requires_human_review = False
review_status = not_required
```

When human review is required:

```text
requires_human_review = True
review_status = pending
```

The production review status for a review-required case is:

```text
pending
```

It is not:

```text
review_required
```

This contract is explicitly validated because report-level and workflow-level status mismatches can cause downstream operational errors.

---

# 19. Review-Required vs Contextual Findings

The frozen release contains:

```text
Review-required findings: 1
Contextual findings:       316
```

A review-required finding is one that triggers the human-review branch under the defined validation rules.

A contextual finding remains part of the investigation result but does not independently require human review.

The ratio should not be interpreted as a universal expected clinical-review rate.

It reflects this specific frozen release population and the current review-routing rules.

---

# 20. Human Review Architecture

The workflow routes review-required cases as follows:

```text
Validation
    |
    +---- pass ----> validation_passed
    |
    +---- review --> human_review
```

Both paths then proceed to:

```text
final_report
    |
    v
persist_report
```

The machine-generated final report remains a distinct artifact.

Human-review artifacts are not intended to silently overwrite the original machine output.

---

# 21. Step 9C Acceptance Areas

Step 9C validates areas including:

- final report presence;
- report case identity;
- report finding counts;
- report review status;
- review-required population;
- contextual finding population;
- reviewer artifact consistency;
- correct routing for the review-required case.

The goal is to ensure that human-review behavior is part of the release contract rather than an informal post-processing step.

---

# 22. Step 9D - Release-Readiness Freeze

Step 9D consolidates the results of Steps 9A, 9B, and 9C into the final release decision.

The final result is:

```text
========================================================================
STEP 9D - RELEASE-READINESS FREEZE
========================================================================
Overall Step 9 status:            PASS

Release gates
------------------------------------------------------------------------
9A - End-to-end regression:       PASS
9B - Robustness:                  PASS
9C - Report / human review:       PASS

Release population
------------------------------------------------------------------------
Cases:                           20 / 20
Findings:                        317 / 317
Review-required findings:        1 / 1
Contextual findings:             316 / 316
Cases requiring review:          1 / 1

Robustness
------------------------------------------------------------------------
9B mutations:                    49 / 49
Repeated failure runs:           10 / 10
Successful recoveries:           10 / 10

Integrity
------------------------------------------------------------------------
Release validation issues:       0
Frozen artifacts:                3

Step 9 complete:                  True
Release ready:                    True
```

---

# 23. Authoritative Evaluation Artifact

The authoritative Step 9 release artifact is:

```text
data/evaluation/step_9_final/
    step_9_release_readiness_summary.json
```

A valid frozen release reports:

```text
status = PASS
step_9_complete = true
release_ready = true
validation_issue_count = 0
```

This artifact is the primary machine-readable release decision.

---

# 24. Release Acceptance Summary

The final release metrics are:

| Metric | Result |
|---|---:|
| Investigation cases | 20 |
| Accepted cases | 20 / 20 |
| Investigation findings | 317 |
| Accepted findings | 317 / 317 |
| Review-required findings | 1 / 1 |
| Contextual findings | 316 / 316 |
| Cases requiring review | 1 / 1 |
| Robustness mutations | 49 / 49 |
| Repeated failure runs | 10 / 10 |
| Successful recovery validations | 10 / 10 |
| Final release validation issues | 0 |
| Step 9 status | PASS |
| Release ready | True |

---

# 25. What PASS Means

For this project, a release PASS means:

- the defined release population executed successfully;
- expected findings were preserved;
- persisted final-report consistency passed;
- human-review routing passed;
- controlled robustness mutations behaved as expected;
- repeated failure scenarios behaved deterministically;
- recovery scenarios returned to valid operation;
- final release validation produced zero unresolved issues.

PASS is therefore an engineering release-acceptance decision.

---

# 26. What PASS Does Not Mean

A PASS does not establish:

- regulatory approval;
- FDA clearance;
- medical-device certification;
- universal clinical correctness;
- diagnostic accuracy across arbitrary populations;
- complete robustness against every possible malformed input;
- safety across all EHR environments;
- autonomous clinical suitability;
- replacement of clinician judgment.

The release should be described as:

```text
accepted against the defined release evaluation criteria
```

rather than:

```text
clinically proven for unrestricted use
```

---

# 27. Evaluation Dataset Limitations

The current evaluation uses a frozen synthetic release population.

This enables:

- deterministic testing;
- repeatable failure injection;
- controlled ground-truth expectations;
- reproducible regression testing.

However, synthetic evaluation also limits what can be concluded about:

- real-world documentation variability;
- institution-specific workflows;
- unusual clinical language;
- incomplete real-world records;
- EHR-specific artifacts;
- real clinician disagreement;
- demographic and institutional distribution shifts.

Future external validation would require additional datasets and review.

---

# 28. Clinical Abnormality Convention

The release uses a strict convention:

> A clinical value is treated as abnormal only when the source explicitly marks it as abnormal.

The system does not independently infer clinical abnormality solely from a numerical value.

This reduces the risk of embedding additional clinical threshold assumptions into the synthetic evaluation framework.

---

# 29. Reproducibility

Step 10A introduced a release-environment check:

```powershell
python .\scripts\check_release_environment.py
```

The validated release environment reports:

```text
Overall status:                   PASS
Reproducible execution ready:    True
```

The checker verifies:

- Python compatibility;
- project structure;
- required imports;
- investigation-case availability;
- frozen Step 9 artifact availability;
- Step 9 status;
- Step 9 completion;
- release readiness;
- zero release-validation issues.

---

# 30. Application-Level Validation

The release-facing application runner has dedicated unit tests.

Current result:

```text
4 passed
```

These tests validate the application boundary independently from the full workflow.

A separate smoke test executes the real production LangGraph:

```powershell
python .\scripts\smoke_test_application_runner.py
```

This provides a release-facing execution check without rerunning the entire Step 9 evaluation suite.

---

# 31. Why Step 8 and Step 9 Are Frozen

The evaluation baseline is meaningful only if the accepted clinical logic and release artifacts remain stable.

Therefore:

```text
Step 8 = frozen
Step 9 = frozen
```

Step 10 packaging work should consume this baseline rather than modify it.

Changes to:

- finding semantics;
- clinical reasoning;
- timeline rules;
- medication reconciliation;
- contradiction logic;
- unsupported-claim logic;
- validation;
- human-review routing;

should trigger a new development and evaluation cycle rather than silently inheriting the Step 9 PASS status.

---

# 32. Evaluation Integrity Principle

The project follows this release principle:

```text
Accepted clinical logic
        |
        v
Frozen evaluation baseline
        |
        v
Release-facing interfaces
```

Not:

```text
Accepted clinical logic
        |
        v
Modify clinical behavior during packaging
        |
        v
Reuse old PASS result
```

This separation protects the meaning of the release evaluation.

---

# 33. Evaluation Artifact Hierarchy

The evaluation outputs can be understood as:

```text
Case-level investigation artifacts
        |
        v
Step 8 quality evaluation
        |
        v
Step 8 frozen baseline
        |
        v
Step 9A regression
        |
        v
Step 9B robustness
        |
        v
Step 9C report/review acceptance
        |
        v
Step 9D release-readiness summary
```

The final release decision is derived from the combined acceptance gates rather than from a single metric.

---

# 34. Recommended Interpretation of Metrics

The reported values should be interpreted narrowly.

## 317 / 317 findings

Means:

```text
all expected findings in the frozen release population
were accepted by the release evaluation
```

It does not mean:

```text
100% sensitivity against all possible clinical findings
```

## 49 / 49 mutations

Means:

```text
all defined controlled robustness scenarios
met their expected acceptance behavior
```

It does not mean:

```text
the system is robust against every possible failure
```

## 10 / 10 repeated failure runs

Means:

```text
the defined invalid scenario produced consistent
failure behavior across repeated executions
```

## 10 / 10 recovery runs

Means:

```text
after restoration of the valid state,
the system successfully recovered in all tested runs
```

## 1 review-required finding

Means:

```text
one finding in this release population triggered
the defined human-review rules
```

It does not establish a general clinical-review rate.

---

# 35. Future Evaluation Directions

Future evaluation may extend into areas such as:

- larger synthetic populations;
- independent external datasets;
- clinician review;
- inter-rater agreement;
- longitudinal record complexity;
- noisy OCR-derived documents;
- partially missing clinical histories;
- institution-specific document structures;
- real-world medication reconciliation complexity;
- calibration of finding confidence;
- precision and recall of individual finding types;
- latency and throughput;
- LLM nondeterminism;
- cost evaluation;
- security and privacy testing;
- adversarial prompt or document manipulation;
- demographic or institutional distribution shifts.

These areas are not part of the current frozen Step 9 release claim unless separately evaluated.

---

# 36. Current Evaluation Status

```text
Step 8 - Evaluation & Refinement
Status: PASS
State: COMPLETE / FROZEN

Step 9A - End-to-End Regression
Status: PASS

Step 9B - Robustness Testing
Status: PASS

Step 9C - Final Report / Human Review Acceptance
Status: PASS

Step 9D - Release-Readiness Freeze
Status: PASS

Step 9 complete:
True

Release ready:
True

Final release validation issues:
0
```

---

# 37. Related Documentation

Project overview:

```text
README.md
```

Installation and first run:

```text
QUICKSTART.md
```

Operational procedures:

```text
OPERATOR_GUIDE.md
```

Release baseline:

```text
RELEASE.md
```

Evaluation methodology:

```text
EVALUATION.md
```